Press release
Global In Vitro Diagnostics Market to Reach USD 157.6 Billion by 2030 | MarketsandMarkets Trademark
According to MarketsandMarkets Trademark , The report global in vitro diagnostics market [https://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] is valued at an estimated USD 109.06 billion in 2025. The size is projected to reach USD 157.63 billion by 2030, at a CAGR of 7.6%.
Browse 882 market data Tables and 67 Figures spread through 739 Pages and in-depth TOC on In Vitro Diagnostics Market.
In Vitro Diagnostics Market Size & Forecast:
* Market Size Available for Years: 2025-2030
* 2025 Market Size: 109.06 billion
* 2031 Projected Market Size: 157.63 billion
* CAGR (2025-2030): 7.6 %
In Vitro Diagnostics Market Trends & Insights:
1. North America accounted for the largest share of 38.7% of the global IVD market in 2024.
2. By product & sevice, the reagents and kits segment held the largest share of 69.0% in 2024, driven by high testing volumes and recurring consumable demand.
3. By technology, the molecular diagnostics segment is projected to register the highest CAGR of 14.5% during the forecast period from 2025 to 2030.
4. By application, the infectious disease segment accounted for the largest share in 2024.
5. By end user, the hospitals & clinics segment constituted the largest end-user segment in 2024.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=703 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=703&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
What is driving this sustained growth in the in vitro diagnostics market?
The increasing awareness of early disease detection among patients and providers has significantly boosted demand for routine screenings and diagnostic testing. Governments worldwide are expanding public health screening programs and increasing healthcare spending to improve access to diagnostic services. As a result, laboratories and hospitals are scaling up capabilities across immunoassay, hematology, glucose monitoring, and molecular testing platforms.
Why is this transformation particularly relevant now?
Healthcare systems are shifting toward personalized medicine, where treatments are tailored based on an individual's genetic, protein, or metabolic profile. This shift is fueling demand for high-specialty tests and advanced diagnostic equipment, particularly in genetic testing and molecular diagnostics. Continued advancements in next-generation sequencing, automation, and digital integration are enhancing diagnostic precision while reducing turnaround time-an essential factor in both acute and chronic disease management.
By product and service, the reagents and kits segment is expected to grow at the fastest rate through 2030.
Laboratories increasingly depend on reagents and diagnostic kits to deliver rapid, accurate, and reproducible results. These consumables are continuously evolving, offering improved sensitivity and ease of use. The growth of personalized medicine is further accelerating demand for niche diagnostic kits designed to identify specific genes and biomarkers. Additionally, stricter regulatory frameworks and quality standards are reinforcing end-user confidence, strengthening adoption across clinical settings.
From a specimen perspective, blood, serum, and plasma specimens held the largest market share in 2024.
Blood-based testing remains the foundation of routine and advanced diagnostics, supporting disease detection across endocrinology, cardiology, infectious diseases, oncology, and autoimmune disorders. Serum and plasma provide reliable matrices for liver function tests, hormone assays, and infection detection. Modern platforms-including immunoassays, molecular diagnostics, and genetic testing-are optimized for these specimen types, ensuring seamless integration into established clinical workflows.
Regionally, North America dominated the global in vitro diagnostics market in 2024.
The region benefits from strong healthcare infrastructure, early adoption of high-throughput systems, lab-on-a-chip technologies, and digital health integration. The healthcare system in the United States continues to expand, with National Health Expenditure growth projected to outpace GDP growth between 2023 and 2032, increasing healthcare's share of GDP from 17.3% in 2022 to 19.7% by 2032. This macroeconomic environment supports sustained investment in advanced diagnostic technologies.
Major diagnostic innovators such as Abbott, Thermo Fisher Scientific Inc., and Becton, Dickinson and Company are playing a pivotal role in advancing the IVD ecosystem. Their robust R&D pipelines, strategic hospital partnerships, and global distribution networks continue to introduce next-generation diagnostic tools to the market.
Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=703 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=703&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Industry and Strategic Implications:
For CEOs and CFOs, the expansion of the in vitro diagnostics market signals long-term revenue opportunities aligned with preventive care and chronic disease management. For CMOs and healthcare strategists, advanced diagnostics enable earlier intervention, risk stratification, and improved patient outcomes.
As healthcare delivery models transition toward value-based care, diagnostics are no longer ancillary-they are foundational. Organizations investing in automation, molecular testing, and data-integrated platforms will gain competitive advantages in accuracy, scalability, and cost efficiency.
Competitive Landscape:
The global IVD market features strong participation from leading life sciences and diagnostics companies, including Danaher, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Illumina, Inc., Hologic, Inc., bioMerieux, Sysmex Corporation, Agilent Technologies, Inc., Qiagen, DiaSorin S.p.A., Grifols, S.A., Werfen, and QuidelOrtho Corporation, among others. These companies continue to invest in innovation, automation, and global expansion strategies to strengthen their market positions.
Market Outlook
Healthcare leaders and investors seeking sustainable growth must prioritize strategic engagement with the in vitro diagnostics market. As early detection, personalized medicine, and advanced molecular testing reshape clinical decision-making, organizations that align with high-growth IVD technologies will be positioned to drive both clinical excellence and financial performance through 2030 and beyond.
Related Reports:
Hematology Analyzers and Reagents Market [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153222146&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] - Global Forecast to 2029
US In Vitro Diagnostics Market [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=66290979&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] - Global Forecast to 2031
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=global-in-vitro-diagnostics-market-to-reach-usd-1576-billion-by-2030-marketsandmarkets]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global In Vitro Diagnostics Market to Reach USD 157.6 Billion by 2030 | MarketsandMarkets Trademark here
News-ID: 4411646 • Views: …
More Releases from ABNewswire
Medical Aesthetics Market worth $40.70 billion by 2031 | MarketsandMarkets Trade …
Medical Aesthetics Market by Product (Botox, Filler, Peel, Liposuction, Microneedling, Hair Removal, Laser Resurfacing, RF, Phototherapy), Procedure (Surgical, Non-surgical), End User (Hospital, Beauty Clinic, Spa), and Region - Global Forecast to 2031
According to MarketsandMarkets Trademark , The report Global Medical Aesthetics Market [https://www.marketsandmarkets.com/Market-Reports/medical-aesthetics-market-885.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] is projected to grow from USD 19.54 billion in 2025 and to reach USD 40.70 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 13.0%
Browse…
Boreal Energy Solutions Ranked #1 in Independent "Best Solar Companies in Edmont …
Edmonton, AB - CX Research Institute announced today that Boreal Energy Solutions has been ranked the top residential solar provider in its new report, "Best Solar Companies in Edmonton, Alberta (Certified & Residential Solar Installation Experts): A Research-Based Comparative Analysis." Boreal Energy Solutions achieved a leading composite score of 91 out of 100 points, placing it first among a field of Edmontonserving solar firms evaluated for residential service scope, professionalism,…
Open Radio Access Network Market Overview 2030: Growth, Share, Value, Size, and …
Open Radio Access Network (Open RAN) Market Size, Share, Growth Analysis, By Offering (Hardware, Software, Services), Network Deployment (Public and Private), Frequency Band (Sub-6GHz, mmWave), Deployment Phase, & Region - Global Industry Forecast to 2030.
The size of the worldwide Open Radio Access Network market [https://www.marketsandmarkets.com/Market-Reports/open-ran-market-153445936.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=openranmarket] is expected to increase at a compound annual growth rate (CAGR) of 39.4%, from USD 2.8 billion in 2024 to USD 20.9 billion by 2030.…
Maribeth Lynch Recognized as Top-Producing Shrewsbury Realtor in 2025
Lamacchia Realty Shrewsbury's #1 Real Estate Brokerage by Sales Volume and Transaction Sides in 2025
Maribeth Lynch [https://maribethlynchrealestate.com/] has been recognized as one of Shrewsbury's highest-ranking real estate agents [https://maps.app.goo.gl/JXtyY1psDBrC4rcG7] for 2025, contributing to Lamacchia Realty's #1 brokerage ranking in the community. According to MLSPIN data, Lamacchia Realty led Shrewsbury by both sales volume and transaction sides throughout 2025 .
"I'm fortunate to work for a great company which recognizes our achievements…
More Releases for Vitro
Prominent In-Vitro Transcription Templates Market Trend for 2025: Innovative Adv …
"What industry-specific factors are fueling the growth of the in-vitro transcription templates market?
The increasing focus on gene therapy is expected to propel the growth of the in-vitro transcription templates market. Gene therapy aims to treat or prevent diseases by correcting defective genes, and its growing focus is due to advances in technologies like CRISPR. In-vitro transcription templates are used to produce the RNA molecules necessary for gene therapy, aiding in…
In Vitro Diagnostics (IVD) Market
With the watchful use of established and advanced tools such as SWOT analysis and Porter's Five Forces Analysis, this market report has been structured. While preparing this In Vitro Diagnostics (IVD) Market research report, few of the attributes that have been adopted include highest level of spirit, practical solutions, committed research and analysis, innovation, integrated approaches, and most up-to-date technology.
Every possible effort has been taken while researching and analysing…
In-Vitro Diagnostics Market - Unlocking Insights, Shaping Medical Decision-Makin …
Newark, New Castle, USA - new report, titled In-Vitro Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the In-Vitro Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global In-Vitro Diagnostics market. The report offers an overview of the market, which…
Vitro Fertilization Market Size to Hit $1024.2 Million by 2028 | Vitro Fertiliza …
Market Overview:
According to our experience research team, Vitro Fertilization Market was valued at USD 617.5 Million in 2021, and the global Vitro Fertilization industry is projected to reach a value of USD 1024.2 Million by 2028, at a CAGR of 8.8% during the forecast period 2022-2028
Vantage Market Research is a collection of market research studies on several industries, such as Chemicals, semiconductors & Electronics, Food & Beverages Technology, Energy &…
Potential Opportunities of In-Vitro Diagnostics Market
The global in-vitro diagnostics market is likely to grow at a high rate due to the increasing prevalence of chronic disease around the world, finds Fortune Business Insights in a report, titled "In-vitro Diagnostics: Global Market Analysis, Insights and Forecast, 2019-2026." In Vitro Diagnostics (IVD) is used to detect any type of infection or disorder with the help of specimen from the related subject. This is beneficial for people…
Europe In-vitro Diagnostics Market
As per the latest report by Graphical Research titled “Europe In-vitro Diagnostics Market analysis based on Product Type, Service Type, Technology, Application, End-User, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 – 2024”, Estimated to reach USD 21 billion by 2024.
Major industry competitors operating in Europe in-vitro diagnostics market are Abbott, Becton Dickinson, BioRad, BioMerieux, Cephied, Danaher, Grifols, Johnson & Johnson, Luminex, Roche Diagnostics, Siemens,…
